Abstract
Background: Sporotrichosis is a fungal infection caused by species of the Sporothrix genus. Presently, the prevalence of sporotrichosis in the Americas is unknown, so this study aims to analyze the cases reported in the past 10 years. Methods: An advanced search was conducted from 2012 to 2022 in English and Spanish in PUBMED, SciELO, and Cochrane, with the terms: “sporotrichosis”, “lymphocutaneous sporotrichosis”, “fixed sporotrichosis”, “mycosis”, “Sporothrix spp.”, “Sporothrix complex”, “S. schenckii sensu stricto”, “S. schenckii sensu lato”, “S. globose”, “S. brasiliensis”, “S. luriei”. Sporotrichosis is a fungal infection caused by species of the Sporothrix genus associated with “pathogenicity” or “epidemiology”. Results: A total of 124 articles were found in the Americas, corresponding to 12,568 patients. Of these, 87.38% of cases were reported in South America, 11.62% in North America, and 1.00% in Central America and the Caribbean. Brazil, Peru, and Mexico had the highest number of cases. The most prevalent etiological agents were S. schenckii complex/Sporothrix spp. (52.91%), S. schenckii (42.38%), others (4.68%), and Not Determined (ND) (0.03%). The most frequent form of the disease was lymphocutaneous infection; however, the infection type was not determined in 5639 cases. Among the diagnostic methods, culture was the most used. Conclusions: There is a high occurrence of cases reported in the literature. South America is the region with the highest number of reports because of its environment (climate, inhalation of spores, etc.), zoonotic transmission (scratches and sneezes from contaminated animals), and possible traumatic inoculation due to outdoor activities (agriculture, gardening, and related occupations). Molecular diagnosis has not been sufficiently developed due to its high cost.
Keywords: sporotrichosis, Sporothrix schenckii sensu stricto, Sporothrixschenckii complex, lymphocutaneous sporotrichosis, fixed cutaneous sporotrichosis, disseminated sporotrichosis, the Americas
1. Introduction
Sporotrichosis is a fungal infection caused by thermo-dimorphic fungi species of the Sporothrix genus. Previously, the classification of the species of sporotrichosis was conducted through the classification of the Sporothrix schenckii complex, which included Sporothrix schenckii sensu stricto, Sporothrix brasiliensis (S. brasiliensis), Sporothrix globosa (S. globosa), Sporothrix luriei (S. lurieri), Sporothrix pallida (S. pallida), Sporothrix mexicana (S. mexicana), and Sporothrix chilensis (S. chilensis) [1,2]. However, since 2016, the taxonomical classification of Sporothrix has been changed into a clinical clade that includes Sporothrix schenckii, S. globosa, S. brasiliensis, and S. luriei. On some occasions, the species of the environmental clade, such as S. pallida, S. mexicana, and S. chilensis may cause infection upon contact with an individual [1,2,3,4]. The infections occur mainly cutaneously or subcutaneously with lymphatic involvement [1,2,3,4]. This infection has been considered the most frequent subcutaneous mycosis in Latin America [2]. Such infections can be difficult to diagnose with the naked eye since they can be similar to infiltrative or ulcerative lesions from vascular and inflammatory disorders [1,3].
For this subcutaneous infection to develop, a direct trauma must occur first. For example, inoculation occurs when the skin is punctured by plants with thorns, gardeners are a classic case of this. Also, inoculation can occur through fomites that contact contaminated soil. For instance, people who wear sandals can suffer trauma from stones, firewood, or thorns with fungal spores on their surface [2,3]. With all the above, it can be inferred that this type of fungal infection is associated with regions where the main livelihood is agriculture, that is, in environments where the climate is tropical and subtropical. Another form of transmission, which has been increasing in recent times in some regions of the continent such as Brazil, Argentina, Paraguay, and Panama, has been reported to result from scratches, bites, pecks, and stings from different animals [1,2,3,4].
There are several techniques for detecting sporotrichosis, including Sabouraud dextrose agar cultures, lactophenol blue or erythromycin staining, histopathological studies, and PCR sequencing, among others [5,6,7] (Figure 1).
As for the clinical forms of sporotrichosis, various types have been described, such as the lymphocutaneous, fixed cutaneous, and, as mentioned earlier, the disseminated or hematogenous forms where both organs and tissues can be affected [5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28]. The latter is the rarest because the recommended antifungal regimens are usually effective; however, in patients with alterations in cellular immunity, these infections can spread [2,3,4].
2. Materials and Methods
An advanced search was conducted in English and Spanish languages in the engines Medical Literature Analysis and Retrieval System Online (MEDLINE/PUBMED), Scientific Electronic Library Online (SciELO), and Cochrane Database. Because the systematic review was performed for the 10 last years (2012–2022), both taxonomical classifications were used. The applied terms were “sporotrichosis”, “lymphocutaneous sporotrichosis”, “fixed sporotrichosis”, “Sporothrix spp.” and “Sporothrix schenckii complex”, “S. schenckii sensu stricto”, and “S. schenckii sensu lato”, Sporothrix schenckii, (Sporothrix schenckii), Sporothrix brasiliensis (S. brasiliensis), Sporothrix globosa (S. globosa), Sporothrix luriei (S. lurieri), Sporothrix pallida (S. pallida), Sporothrix mexicana (S. mexicana), and Sporothrix chilensis (S. chilensis) associated with “pathogenicity” or “epidemiology”. The total number of articles found was 243. The review was performed based on the preferred reporting items for systematic reviews and meta-analyses (PRISMA) (Figure 2). After reading the titles and reviewing the complete text, the most relevant papers to develop this article were identified. At the end of the selection process, 127 articles were chosen. The review was performed based on the preferred reporting items for systematic reviews and meta-analyses (PRISMA).
3. Epidemiology of Sporotrichosis in North America
A total of 48 publications related to sporotrichosis were found in North America [5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52]. There were 1460 patients in total associated with infection caused by species of the genus Sporothrix. According to the previous classification, it was found that in Canada, only two case reports were found, one from Ontario and the other from Toronto [5,6]. In the US, 27 reports containing 1 clinical case were found (81.5% S. schenckii, 18.5% Sporothrix spp., S. schenckii complex, and S. schenckii sensu lato) [7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33]. Of these, seven cases came from California, three from Oklahoma, two cases from Kansas, Texas, Arizona, Minnesota, and Florida, one case from Michigan, Nebraska, Oregon, Pennsylvania, and finally, one case without a specific city or region. In Mexico, there were 19 reports registered with 1431 reported cases (84.7% Sporothrix spp., 14.47% S. schenckii, 0.55% S. globosa, 0.21% S. schenckii sensu stricto, 0.07% S. mexicana) [34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52]. Jalisco reported 1060 cases, Guerrero 150, Nayarit 23, Zacatecas 21, Michoacan 20, Guanajuato 14, Oaxaca 9, Puebla, and San Luis Potosí 8 each, Mexico City 6, Chihuahua, Nuevo León, Querétaro, and Veracruz 2 each, Baja California, Durango, State of Mexico, and Morelos 1 each, and 99 cases were reported with an unspecified city (Table 1). When classifying according to the current taxonomy [1,2,3,4], we can mention that in Canada, 50% of the sporotrichosis was due to S. schenckii and 50% to Sporothrix spp. [5,6]. In the US, it was reported that Sporothrix spp. (85.19%) and S. schenckii (14.81%) were responsible for this pathology [7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33]. Finally, in Mexico, 85.05% were due to Sporothrix spp., 14.33% S. schenckii, 0.55% S. globosa, and 0.07% S. mexicana [34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52].
Table 1.
Region | Country | City | Number of Reported Cases | Vulnerable Population | Diagnostic Method | Type of Sporotrichosis | Etiological Agents (%) |
References | ||
---|---|---|---|---|---|---|---|---|---|---|
Sex | Age (Years) | Taxonomy | ||||||||
Before 2017 | After 2017 | |||||||||
North America | Canada | Ontario | 1 | Male | 44 | PCR sequencing (ITS region) | Disseminated | S. schenckii | S. schenckii | [5] |
Toronto | 1 | Male | 78 | Fungal culture, Biopsy (Histopathology) |
Lymphocutaneous | S. schenckii complex | Sporothrix spp. | [6] | ||
USA | California | 1 | Female | 7 | Fungal culture Biopsy (Histopathology) |
Lymphocutaneous | S. schenckii | Sporothrix spp. | [7] | |
Minnesota | 1 | Male | 61 | Fungal culture | Disseminated | S. schenckii | Sporothrix spp. | [8] | ||
ND | 1 | Female | 87 | Fungal culture | Lymphocutaneous on the eyelid | S. schenckii | Sporothrix spp. | [9] | ||
Pennsylvania | 1 | Male | 67 | Fungal culture Biopsy (Histopathology) |
Lymphocutaneous | S. schenckii | Sporothrix spp. | [10] | ||
Texas | 1 | Male | 34 | Fungal culture Biopsy (Histopathology) |
Disseminated | Sporothrix spp. | Sporothrix spp. | [11] | ||
Texas | 1 | Male | 9 | Fungal culture Biopsy (Histopathology) |
Lymphocutaneous on the eyelid | S. schenckii | Sporothrix spp. | [12] | ||
California | 1 | Female | 41 | Fungal culture | Lymphocutaneous | S. schenckii | Sporothrix spp. | [13] | ||
Oregon | 1 | Male | 53 | Fungal culture | Disseminated | Sporothrix spp. | Sporothrix spp. | [14] | ||
Oklahoma | 1 | Male | 66 | Latex agglutination test | Disseminated | S. schenckii | Sporothrix spp. | [15] | ||
Florida | 1 | Male | 33 month-Old | Fungal culture Biopsy (Histopathology) |
Atypical lymphadenitis | S. schenckii | Sporothrix spp. | [16] | ||
Minnesota | 1 | Male | 49 | Fungal culture | Pulmonary sporotrichosis | Sporothrix spp. | Sporothrix spp. | [17] | ||
Arizona | 1 | Male | 56 | Fungal culture | Lymphocutaneous and disseminated (10 months later) | S. schenckii | Sporothrix spp. | [18] | ||
California | 1 | Male | 39 | Fungal culture | Sporothrical arthritis | S. schenckii | Sporothrix spp. | [19] | ||
California | 1 | Male | 89 | Fungal culture Biopsy (Histopathology) |
Disseminated | S. schenckii | Sporothrix spp. | [20] | ||
Michigan | 1 | Female | 57 | Fungal culture Biopsy (Histopathology) |
Lymphocutaneous | S. schenckii | Sporothrix spp. | [21] | ||
California | 1 | Male | 34 | Latex agglutination test | Chronic meningitis | S. schenckii | Sporothrix spp. | [22] | ||
Kansas | 1 | Male | 33 | Fungal culture MALDI-TOF |
Sporothrical arthritis | S. schenckii | Sporothrix schenckii | [23] | ||
Oklahoma | 1 | Male | 44 | Fungal culture Biopsy (Histopathology) |
Pulmonary sporotrichosis | S. schenckii sensu lato | Sporothrix spp. | [24] | ||
California | 1 | Male | 41 | Fungal culture | Sporothrical arthritis | S. schenckii | Sporothrix spp. | [25] | ||
California | 1 | Female | 35 | Fungal culture | Disseminated | S. schenckii | Sporothrix spp. | [26] | ||
Nebraska | 1 | Male | 62 | Fungal culture Biopsy (Histopathology) |
Disseminated | S. schenckii | Sporothrix spp. | [27] | ||
Boston | 1 | Female | 35 | MALDI-TOF | Fixed cutaneous | S. schenckii | S. schenckii | [28] | ||
Kansas | 1 | Male | 30 | Fungal culture Biopsy (Histopathology) |
Disseminated | S. schenckii | Sporothrix spp. | [29] | ||
Florida | 1 | Male | 76 | History and physical examination | Lymphocutaneous | Sporothrix spp. | Sporothrix spp. | [30] | ||
Oklahoma | 1 | Male | 23 | Fungal culture | Lymphocutaneous | S. schenckii complex | Sporothrix spp. | [31] | ||
Washington | 1 | Female | 44 | Fungal culture PCR sequencing (ITS 1–2) |
Disseminated | S. schenckii | S. schenckii | [32] | ||
Arizona | 1 | Female | 72 | PCR DNA sequencing | Laryngotracheal granulomatous disease | S. schenckii | S. schenckii | [33] | ||
Mexico | Veracruz | 1 | Male | 39 | Fungal culture Biopsy (Histopathology) |
Atypical | S. schenckii | Sporothrix spp. | [34] | |
Puebla | 1 | Male | 36 | Fungal culture Biopsy (Histopathology) |
Disseminated | S. schenckii | Sporothrix spp. | [35] | ||
Oaxaca | 1 | Male | 13 | Fungal culture | Lymphocutaneous on the left hand, forearm, and upper arm | Sporothrix spp. | Sporothrix spp. | [36] | ||
Mexico City | 1 | Male | 54 | Fungal culture Biopsy (Histopathology) |
Disseminated (Testicular involvement) | S. schenckii | Sporothrix spp. | [37] | ||
Guerrero | 1 | Female | 36 | Fungal culture Biopsy (Histopathology) |
Disseminated | Sporothrix spp. | Sporothrix spp. | [38] | ||
Durango | 1 | Male | 68 | Fungal culture Biopsy (Histopathology) |
Disseminated | Sporothrix spp. | Sporothrix spp. | [39] | ||
ND | 24 | Male (16) Female (8) |
Average: 35.5 | PCR sequencing (calmodulin gene) | Cutaneous disseminated 16 (66.7%) Cutaneous disseminated + Mucosal 3 (12.5%) Joint 1 (4.1%) Visceral 1 (4.1%) Fungaemia 1 (4.1%) Mucosal + Visceral + Fungemia: 1 (4.1%) Visceral + Fungaemia 1 (4.1%) |
S. schenckii 23 (95.5%). S. globosa 1 (4.5%) |
S. schenckii 23 (95.5%). S. globosa 1 (4.5%) |
[40] | ||
ND | 55 | Male (34) ND Female (18) |
Sporotrichin Skin Test Fungal culture |
Lymphocutaneous 32 (58.2%) Fixed cutaneous 19 (34.5%) Disseminated 4 (7.3%) |
S. schenckii 54 (98%) S. globosa 1 (2%) |
S. schenckii 54 (98%) S. globosa 1 (2%) |
[41] | |||
Guerrero | 73 | Male (33) Female (40) |
Average: 25.8 | Fungal culture Biopsy (Histopathology) |
Lymphocutaneous: 41 (56.16%) Fixed cutaneous 24 (32.87%) Disseminated 8 (10.95%) |
S. schenckii | S. schenckii | [42] | ||
Chihuahua | 1 | Female | 84 | Multiplex PCR (Calmodulin gene) | Fixed cutaneous (Auricular sporotrichosis) | S. schenckii (sensu stricto) | S. schenckii | [43] | ||
Baja California | 1 | Male | 23 | Fungal culture Biopsy (Histopathology) |
Lymphocutaneous | S. schenckii | Sporothrix spp. | [44] | ||
San Luis Potosi 8 Puebla 3 Mexico City 2 Queretaro 2 Guanajuato 2 Jalisco 1 Zacatecas 1 Michoacan 1 Morelos 1 State of Mexico 1 |
22 | ND | PCR sequencing (Calmodulin and calcium-calmodulin-dependent kinase genes) | Lymphocutaneous: 17 (77.3%) Fixed cutaneous 4 (18.2%) Disseminated 1 (4.5%) |
S. schenckii: 18 (81.8%) S. globosa 4 (18.2%) |
S. schenckii: 18 (81.8%) S. globosa 4 (18.2%) |
[45] | |||
Puebla 4 Nuevo Leon 2 Oaxaca 6 Mexico City 3 Jalisco 2 |
17 | ND | PCR sequencing (Calmodulin gene) | Lymphocutaneous: 16 (94.11%) Disseminated: 1 (5.88%) |
S. schenckii: 16 (94.11%) S. globosa 1 (5.88%) |
S. schenckii: 16 (94.11%) S. globosa 1 (5.88%) |
[46] | |||
Guerrero | 76 | Male (35) Female (41) |
<18: 37 >18: 39 |
Fungal culture Biopsy (Histopathology) |
Lymphocutaneous 43 (56.8%) Fixed cutaneous 24 (32.3%) Disseminated 8 (11%) |
Sporothrix spp. | Sporothrix spp. | [47] | ||
Jalisco 1057 Nayarit 23 Zacatecas 20 Michoacan 19 Guanajuato 12 Veracruz 1 Chihuahua 1 |
1134 | Male (669) Female (465) |
ND | Lymphocutaneous: 782 (69%) Fixed cutaneous: 308 (27.2%) Disseminated 44 (38.8%) |
S. schenckii complex | Sporothrix spp. | [48] | |||
ND | 1 | Male | 45 | PCR sequencing (Calmodulin gene) | Disseminated | S. schenckii complex | S. schenckii | [49] | ||
ND | 1 | Male | 56 | Fungal Culture Biopsy (Histopathology) PCR sequencing (ITS and calmodulin gene) |
Fixed cutaneous sporotrichosis |
S. mexicana | S. mexicana | [50] | ||
ND | 18 | Male (10) Female (8) |
ND | PCR sequencing (ITS regions) | Lymphocutaneous 13 (72.2%) Fixed cutaneous 5 (27.8%) |
S. schenckii 17 (94.4%) S. globosa: 1 (5.6%) |
S. schenckii 17 (94.4%) S. globosa: 1 (5.6%) |
[51] | ||
Oaxaca | 2 | Male | 61 | Multiplex PCR (Calmodulin gene) | Fixed cutaneous 1 (50%) Disseminated 1 (50%) |
S. schenckii sensu stricto | S. schenckii | [52] | ||
Male | 21 |
ND: Not Determined.
The most frequent variety reported was lymphocutaneous with 956 cases, followed by fixed cutaneous with 388 cases, and the disseminated form with 83 [5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52]. A lymphocutaneous presentation evolved into a disseminated after 10 months. The least frequent varieties were the disseminated cutaneous with 16 cases, disseminated cutaneous with affected mucous membranes and arthritis with 3 cases each, and the pulmonary form with 2 cases. Finally, lymphadenitis, meningitis, laryngotracheal joint, visceral fungemia, visceral infection associated with fungemia, an atypical presentation, and a visceral presentation with fungemia and mucosal involvement were only reported in one case each. The most common reported etiological agent with the new taxonomical classification was Sporothrix spp. with 85.00% (1241/1460), followed by S. schenckii with 14.38% (210/1460), S. globosa with 0.54% (8/1460), and S. mexicana with 0.068% (1/1460) [5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52].
In terms of the diagnosis, fungal culture was the most frequently used diagnostic methodology with 33/48, followed by histopathological examination with 20/48. It is worth noting that the histopathological examination was always accompanied by fungal cultures. PCR sequencing was the third method used in 11/48 studies. For this diagnostic tool, the Calmodulin gene was used in 7 cases, the ITS1-2 region in 3 cases, and an unspecified gene in 1 case. Also, the MALDI-TOF and the agglutination latex test were used for diagnosis in two reports. Finally, the use of the Sporotrichin Skin Test and physical examination was mentioned in one report, and one case was reported without describing the employed diagnostic method [5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52].
4. Epidemiology of Sporotrichosis in Central America and the Caribbean
Only 8 publications with 126 cases of sporotrichosis were found in Central America and the Caribbean [53,54,55,56,57,58,59,60]. In the only article found from Costa Rica during the search period, 57 isolates were analyzed in San José, finding the presence of 2 species: S. schenckii sensu stricto (93%), S. brasiliensis (3.5%), and Sporothix spp. (3.5%) [53]. On the other hand, there were 3 reports in Guatemala with 65 cases (98.5% Sporothrix spp. and 1.5% S. schenckii sensu stricto), with all cases being from Guatemala City [54,55,56]. Finally, reports of a single case were found in Honduras (Tegucigalpa); the agent responsible for the infection was S. schenckii, and in Panama (Correa District), the agent was not determined [57,58]. In the Caribbean, only two reports of S. schenckii sensu lato from Cuba were found [59,60]. Regarding the new taxonomic classification, it was determined that in Costa Rica, 93% of the cases were caused by S. schenckii, 3.5% by S. brasiliensis, and 3.5% by Sporothix spp. [53]. Meanwhile, in Guatemala, the main pathogenic agent was Sporothrix spp. with 98.5% and S. schenckii with 1.5% [54,55,56]. In Honduras and Panama, it was observed that the agent Sporothrix spp. was responsible for sporotrichosis, with one case per country (100%) [57,58]. In Cuba, there were two reports of a case due to Sporothrix spp., which represents 100% [59,60].
The most frequently reported form was lymphocutaneous with 39 cases (30.95%), followed by fixed cutaneous with 26 (20.63%), the disseminated form with 2 (1.59%), 1 case of chancre (0.79%), and 58 ND cases (46.03%) [53,54,55,56,57,58,59,60]. The most common etiological agents noted were Sporothrix spp. with 55.56% (70/126), S. schenckii with 42.85% (54/126), and S. brasiliensis with 1.59% (2/126) [53,54,55,56,57,58,59,60].
Regarding diagnosis, fungal culture was used as a diagnostic method in all articles (8/8), followed by histopathological examination (5/8). In this case, also, the histopathological examination was always accompanied by fungal cultures. PCR sequencing (2/8) employing the calmodulin gene in one article and the ITS1-2 region in the other was also used as a diagnostic tool. Lastly, diagnosis with microscopy using lactophenol blue was mentioned in two reports (Table 2) [53,54,55,56,57,58,59,60].
Table 2.
Region | Country | City | Number of Reported Cases | Vulnerable Population | Diagnostic Method | Type of Sporotrichosis | Etiological Agents (%) |
References | ||
---|---|---|---|---|---|---|---|---|---|---|
Sex | Age (Years) | Taxonomy | ||||||||
Before 2017 | After 2017 | |||||||||
Central America | Costa Rica | San José | 57 (1994–2015) |
No data | Direct microscopy, culture, PCR (enzymatic restriction and sequencing of the calmodulin gen) | ND |
S. schenckii sensu stricto 53 (93%) S. brasiliensis 2 (3.5%) Sporothrix spp. 2 (3.5%) |
S. schenckii 53 (93%) S. brasiliensis 2 (3.5%) Sporothrix spp. 2 (3.5%) |
[53] | |
Guatemala | Guatemala City | 11 | Male 7 Female 4 |
Average 49 years | Fungal culture, Histopathology |
Fixed cutaneous 9 (81.8%) Lymphocutaneous 2 (18.2%) |
Sporothrix spp. (100%) | Sporothrix spp. (100%) | [54] | |
Guatemala City | 53 (2007–2016) |
Male 33 Female 20 |
Average 44.1 years | Fungal culture, microscope with Lactophenol cotton blue |
Lymphocutaneous 33 (62.2%) Fixed cutaneous 17 (32.1%) Disseminated 2 (3.8%) Chancre 1 (1.9%) |
Sporothrix schenckii complex. (100%) |
Sporothrix spp. (100%) |
[55] | ||
Guatemala City | 1 | ND | Fungal culture, PCR sequencing (ITS 1- 2 and β -tubulin) |
ND | Sporothrix schenckii sensu stricto | Sporothrix schenckii | [56] | |||
Honduras | Tegucigalpa | 1 | Male 1 | 14 years |
Fungal culture | Lymphocutaneous 1 (100%) |
S. schenckii | Sporothrix spp. | [57] | |
Panamá | Chorrera District | 1 | Male 1 | 34 years | Clinical, Direct Microscopy, Fungal culture. |
Lymphocutaneous 1 (100%) |
ND | Sporothrix spp. | [58] | |
Caribbean | Cuba | Pinar del Río | 1 | Female 1 | 57 years | Histopathology Fungal culture |
Lymphocutaneous |
Sporothrix schenckii
sensu lato (100%) |
Sporothrix spp. (100%) |
[59] |
Cumanayagüa | 1 | Male | 67 | Histopathology, Fungal culture, Microscopy with lactophenol cotton blue |
Lymphocutaneous |
Sporothrix schenckii sensu lato (100%) |
Sporothrix spp. (100%) |
[60] |
ND: Not Determined.
5. Epidemiology of Sporotrichosis in South America
A total of 68 publications with 11,050 cases of sporotrichosis were found in South America [61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131]. Of these, 4 reports were found in Argentina during the analyzed period with 38 cases, of which 9 were caused by S. schenckii sensu stricto (23.68%), 26 by S. brasiliensis (68.52%), 1 by S. globosa (2.6%), 1 by S. schenckii (2.6%), and 1 by S. schenckii complex (2.6%) [61,62,63,64]. Brazil reported 42 articles with 5546 analyzed cases [65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106], identifying Sporothrix spp. and S. schenckii complex as the causative agent in 4906 cases (88.46%), S. schenckii in 302 (5.45%), S. brasiliensis in 125 (2.25%), Sporothrix sensu lato in 110 (1.98%), S. globosa plus S. schenckii in 91 cases (1.64%) Sporothrix sensu stricto in 5 (0.09%), S. globosa in 4 (0.07%), and S. mexicana in 3 (0.05%) during the studied period. In Colombia, 4 reports were found, adding up to 50 cases [56,107,108,109].S. Schenckii sensu stricto was identified in 22 cases (44.00%), Sporothrix spp. in 15 (30.00%), S. globosa in 12 (24.00%) and S. schenckii sensu lato in 1 (2.00%). Likewise, in Chile, 3 reported cases detected Sporothrix spp. in 1 (33.33%), S. globosa in 1 (33,33%), and Sporothrix pallida in 1 (33.33%) [110,111,112]. A total of 13 cases of Sporothrix spp. and S. schenckii complex (100%) were reported in Paraguay [113,114]. In Peru, from 4792 cases, S. schenckii was found in 4656 (97.16%), Sporothrix spp. and the Sporothrix complex in 116 (2.42%), S. schenkii sensu stricto in 19 (0.40%), and Sporothrix sensu lato in 1 (0.02%) [115,116,117,118,119,120,121,122,123]. There was 1 report of 157 cases of Sporothrix spp. (100%) found in Uruguay [124]. Finally, there were 4 reports from Venezuela with 452 cases of Sporothrix spp., and the Sporothrix complex was found in 220 of those cases (48.67%), S. schenckii sensu lato in 130 (28.76%), S. schenckii in 42 (9.29%), S. schenckii sensu stricto in 17 (3.76%), S. globosa in 39 (8.63%), 1 case of Ophiostoma stenoceras (0.22%) and 3 cases were ND (0.66%) [125,126,127,128].
Regarding the new taxonomic classification, in Argentina, 26.31% were S. schenckii, 68.42% S. brasiliensis, 2.63% S. globosa, and 2.63% Sporothrix spp. [61,62,63,64]. In Brazil, the main pathogenic agent was Sporothrix spp. with 95.56%, S. brasiliensis 2.25%, S. globosa plus S. schenckii 1.64%, S. schenckii 0.41%, S. globosa 0.07%, and S. mexicana 0.05% [65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106]. In Colombia, S. schenckii 44.00%, Sporothrix spp. 32.00%, and S. globosa 24.00% were the principal mycotic agents [56,107,108,109]. Regarding Chile, the pathogenic agents were Sporothrix spp., S. globose, and S. pallida (33.33% each) [110,111,112]. In Paraguay, the unique agent found was Sporothrix spp. (100%) [113,114]. For Peru, the most important pathogenic agents were Sporothrix spp. (99.54%), and S. schenckii (0.46%) [115,116,117,118,119,120,121,122,123]. In Uruguay, 100% of the cases were due to Sporothrix spp. (100%) [124]. In Venezuela, Sporothrix spp. (80.04%), S. schenckii (13.38%), and S. globose (6.57%) were the types of Sporothrix agents [125,126,127,128].
The most frequent types of disease were lymphocutaneous with 3293 cases (29.47%), fixed cutaneous with 1947 (17.43%), disseminated cutaneous with 34 (0.30%), systemic form with 18 (0.16%), and others with 177 cases (1.60%). However, there were 5702 cases (51.04%) with undetermined types from all the cases diagnosed as sporotrichosis [56,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121,122,123,124,125,126,127,128].
The most common reported etiological agent with the new taxonomical classification was Sporothrix spp. with 95.12% (10,511/11,050), followed by S. schenckii with 1.23% (136/11,050), S. brasiliensis with 2.27% (251/11,050), S. globosa plus S. schenckii with 0.82% (91/11,050), S. globosa with 0.52% (57/11,050), S. mexicana 0.027% (3/11,050), and S. pallida with 0.009% (1/11,050) [56,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,118,119,120].
With reference to diagnosis, fungal culture was used as a diagnostic methodology in almost all articles (67/71), followed by PCR sequencing (26/71), where the calmodulin gene (15/23), the ITS 1-2 region (6/23), and other genes (15/23) were used. Other types of diagnoses (12/71) were applied, such as direct microscopy (19/71), histopathological examination, always accompanied by fungal culture (18/71), and microscopy with lactophenol blue (9/71) (Table 3).
Table 3.
Region | Country | City | Number of Reported Cases | Vulnerable Population | Diagnostic Method | Type of Sporotrichosis | Etiological Agents (%) |
References | ||
---|---|---|---|---|---|---|---|---|---|---|
Sex (Number of Cases) | Age (Years) | Taxonomy | ||||||||
Before 2017 | After 2017 | |||||||||
South America | Argentina | Provincia de Chaco | 1 | Female | 65 | Bronchoalveolar lavage (BAL), Giemsa stain Fungal culture PCR sequencing (ITS 1–2) |
Pulmonary | S. schenckii | S. schenckii | [61] |
Buenos Aires | 16 | Male (4) Female (10) ND (7) |
Average 32.5 | Fungal culture and PCR sequencing (Calmodulin gene) | Lymphocutaneous 33 (42.9%) Fixed cutaneous 17 (19.0%) ND (38.1%) |
S. brasiliensis | S. brasiliensis | [62] | ||
Misiones | 1 | Fungal culture and PCR sequencing (Calmodulin gene) | ||||||||
El Calafate | 4 | Fungal culture, PCR sequencing (Calmodulin gene) and histopathology | ||||||||
Buenos Aires | 15 | ND | Fungal culture (agar potato dextrose and brain heart infusion agar) PCR sequencing (Calmodulin gene) |
ND |
S. schenckii sensu stricto 9 (56.5%) S. brasiliensis 5 (34.7%) S. globosa 1 (8.7%) |
S. schenckii 9 (56.5%) S. brasiliensis 5 (34.7%) S. globosa 1 (8.7%) |
[63] | |||
Buenos Aires | 1 | Female | 5 | Direct microscopy, Fungal culture (Sabouraud agar), Histopalology | Lymphocutaneous | S. schenckii complex | Sporothrix spp. | [64] | ||
Brazil | Rio de Janeiro (Duque de Caxias) |
827 from 2007–2016 | Female (541) Male (286) |
42 | Fungal culture | ND | Sporothrix spp. | Sporothrix spp. | [65] | |
Rio de Janeiro ND Teresópolis ND | 1563 (1999–2008 = 50 (3.20%)) |
Male (16) Female (34) |
Average 47 | Direct microscopy, Fungal culture, PCR sequencing (calmodulin gene) | Lymphocutaneous 24 (48%) Fixed cutaneous 15 (30%) Disseminated cutaneous 6 (12%) disseminated (involving internal tissues) 5 (10%) |
S. brasiliensis 45 45 (90%) S. schenckii sensu stricto 5 (10%) |
S. brasiliensis 45 (90%) S. schenckii 5 (10%) |
[66] | ||
Rio de Janeiro | Group 1 48 (1.33%) Group 2 3570 (98.67%) 1987–2013 |
Group 1 HIV patients Male 33 Female 15 Group 2 Immunocompetent patients Male (1102) Female (2468) |
Average: 38.4 Averag: 46.3 |
Direct microscopy, Fungal culture. | ND | Sporothrix spp. | Sporothrix spp. | [67] | ||
Rio de Janeiro | 21/1750 cases in HIV patients (1.2%) from 1999–2009 | Male (16) Female (5) |
Average: 41.2 | Direct microscopy, Fungal culture, Histopathology | Lymphocutaneous 7 (33.3%) Disseminated 7 (33.3%) widespread cutaneous 5 (23.8%) fixed cutaneous 2 (9.5%) |
S. schenckii sensu lato | Sporothrix spp. | [68] | ||
Rio de Janeiro 16 Duque de Caxias 6 São João de Meriti 2 São Gonçalo 1 Maricá 1 |
26 from 2007–2017 | Female (19) Male (7) |
Average: 25 |
Direct microscopic, Fungal culture | Primary ocular 21 (80.8%) Associated cutaneous disease (3 lymphocutaneous, 1 the fixed cutaneous and 1 the disseminated 5 (19.2%) |
Sporothrix spp. | Sporothrix spp. | [69] | ||
Rio de Janeiro | 86 from 2009–2017 | Male (26) Female (60) |
Average: 36.3 Average: 46 |
Fungal culture Histopathology |
ND | Sporothrix spp. | Sporothrix spp. | [70] | ||
Espíritu Santo | 73 from 2016–2019 | Male Female |
ND | Fungal culture, Microscopy with lactophenol cotton blue, PCR sequencing (Calmodulin gene and Mating type (MAT) gene) |
ND |
S. brasiliensis 55 (76%) S. schenckii sensu stricto 18 (24%) |
S. brasiliensis 55 (76%) S. schenckii 18 (24%) |
[71] | ||
Espíritu Santo | 171 cases from 1982–2012 | Male (138) Female (33) |
Average: 33.42 | Fungal culture | ND | Sporothrix spp. | Sporothrix spp. | [72] | ||
Rio Grande do Sul | 83 from 2010–2016 | ND | Fungal culture | ND | Sporothrix spp. | Sporothrix spp. | [73] | |||
Rio Grande do Sul | 43 from 2006–2015 | Male (31) Female (7) |
Average: 43 | Fungal culture | Lymphocutaneous 22 (51%) Fixed cutaneous 14 (32.5%) Disseminated cutaneous 1 (2.5%) ND 6 (14%) |
Sporothrix spp. | Sporothrix spp. | [74] | ||
Minas Gerais | 282 | Male (153) Female (129) |
Average: 42.52 | Fungal culture, Sporotrichin test, Histophatology, Production of S. schenckii antigens, Enzyme-linked immunosorbent assay |
ND | S. schenckii | Sporothrix spp. | [75] | ||
Brasilia | 91 from 1993–2018 | Male (64) Female (27) |
ND | Direct microscopy, Fungal culture, PCR sequencing (Calmodulin gene) | Lymphocutaneous 34 (37.36%) Cutaneous fixed 6 (6.59%) Disseminated 5 (5.49%) ND 46 (50.55%) |
S. globosa (ND) S. schenckii (ND) |
S. globosa (ND) S. schenckii (ND) |
[76] | ||
São Paulo | 25 from 2003–2013. | Male (18) Female (7) |
Average: 42.48 | Fungal culture Histopathology |
Lymphocutaneous 20 (80%) Fixed cutaneous 5 (20%) |
S. schencki sensu lato | Sporothrix spp. | [77] | ||
São Paulo | 20 from 2012–2020 | Male (9) Female (11) |
Average: 2.2 | Direct microscopy, Fungal culture, Histopathology | Lymphocutaneous 10 (50%) Multiple-inoculation 5 (25%) Fixed-cutaneous 3 (15%) Ocular-mucosal 2 (10%) |
Sporothrix spp. | Sporothrix spp. | [78] | ||
Rio de Janeiro | 1 | Male | 35 | Direct microscopy, fungal culture | Osteomyelitis | S. schenckii complex | Sporothrix spp. | [79] | ||
Rio de Janeiro | 1 | Female | 68 | Direct microscopy (KOH), fungal culture (Sabouraud Dextrose Agar 2%, and Mycosel Agar, Brain Heart Infusion Agar, Potato Dextrose Agar), Lactophenol Cotton Blue and MALDI-TOF MS | Ocular | S. brasiliensis | S. brasiliensis | [80] | ||
Rio Grande do Norte | 1 | Male | 50 | Direct microscopy (KOH), fungal culture (Mycosel Agar), PCR sequencing >(Calmodulin gene) | Pulmonary | S. brasiliensis | S. brasiliensis | [81] | ||
Pelotas | 7 | ND | Gram-stain microscopy, fungal culture (Sabouraud-dextrose agar added with chloramphenicol and Mycosel), PCR sequencing (ITS1 and ITS4 and Calmodulin gene) | Lymphocutaneous 4 (57.1%) Ocular 3 (42.9%) |
S. brasiliensis | S. brasiliensis | [82] | |||
São Paulo | 1 | Female | 12 | Histopatology (Grocott stainin), fungal culture. | Immunoreactive cutaneous | Sporothrix spp. | Sporothrix spp. | [83] | ||
Recife | 1 | Male | 25 | Histopatology (hematoxylin–eosin straining), fungal culture (Sabouraud dextrose agar with chloramphenicol), PCR sequencing (using the species-specific primers Sbra-F and Sbra-R and Calmodulin gene) | Ocular | S. brasilienis | S. brasilienis | [84] | ||
Rio de Janeiro | 1 | Male | 44 | Fungal culture | Disseminated | Sporothrix spp. | Sporothrix spp. | [85] | ||
São Paulo | 2 | Male | 3 and 12 | Fungal culture | Ocular | Sporothrix spp. | Sporothrix spp. | [86] | ||
ND | 1 | Female | 45 | Histopathology, Fungal culture (Sabouraud dextrose agar), PCR sequencing (Whole genome sequencing) |
Cutaneos carbuncle | S. brasiliensis | S. brasiliensis | [87] | ||
Rio de Janeiro | 1 | Male | 11 | Fungal culture (Sabouraud’s dextrose agar), Culture microscopy with Lactofenol blue | Facial Cutaneous | Sporothrix spp. | Sporothrix spp. | [88] | ||
Guarulhos, Sao Paulo | 1 | Male | 56 | Fungal culture, Histopathology (Peryodic Acid Schiff staining), | Disseminated | Sporothrix spp. | Sporothrix spp. | [89] | ||
São Paulo | 1 | Female | 39 | Fungal culture (Sabouraud agar) | Lymphocutaneous | Sporothrix spp. | Sporothrix spp. | [90] | ||
Brasilia | 1 | Male | 26 | Fungal culture | Disseminated | Sporothrix spp. | Sporothrix spp. | [91] | ||
Rio de Janeiro | 4 from 2006–2016 | Female Age ranged from 18–34 |
Average 25 | Fungal culture, PCR sequencing (Primer T3B fingerprintig assay) | Fixed cutaneous 2 (50%) Lymphocutaneous 2 (50%) |
Sporothrix spp. 2 (50%) S. brasiliensis 2 (50%) |
Sporothrix spp. 2 (50%) S. brasiliensis 2 (50%) |
[92] | ||
Rio de Janeiro | 3 from 2006 to 2013 | Male Age ranged from 25–43 |
Average 32 | Fungal culture, PCR sequencing (primer T3B fingerprinting assay ) | Disseminated 3 | S. brasiliensis | S. brasiliensis | [93] | ||
Rio de Janeiro | 1 | Male | 66 | Direct microscopy, fungal culture (Sabouraud dextrose agar, potato dextrose agar, corn meal agar and and brain heart infusion agar), Histopatology, PCR sequencing (Calmodulin gene) | Lymphocutaneous | S. globosa | S. globosa | [94] | ||
Palmeira das Missões | 1 | Male | 73 | Fungal culture | ND | S. schenckii complex | Sporothrix spp. | [95] | ||
Rio de Janeiro | 1 | Male | 5 | Fungal culture and Histopatology | Osteoarticular | S. schenckii | Sporothrix spp. | [96] | ||
Rio de Janeiro | 1 | Male | 61 | Fungal culture, PCR sequencing (primer T3B fingerprinting assay) | Disseminated | S. brasiliensis | S. brasiliensis | [97] | ||
ND | 1 | Male | 49 | Fungal culture | Disseminated | S. schenckii | Sporothrix spp. | [98] | ||
Espírito Santo | 3 | Female | 30 and 10 | Direct microscopy (KOH), fungal culture (Sabouraud Dextrose agar and Mycosel agar®), assimilation of sugar test | Chancre 3 |
S. brasiliensis | S. brasiliensis | [99] | ||
Male | 14 | |||||||||
Rio de Janeiro | 1 | Female | 9 | PCR sequencing (calmodulina gene) | Dacryocystitis | S. brasiliensis | S. brasiliensis | [100] | ||
Rio de Janeiro | 2 | Female | 22 and 27 | Fungal culture, PCR sequencing (Calmodulina gene) | Fixed Cutaneous | S. brasiliensis | S. brasiliensis | [101] | ||
Rio de Janeiro | 1 | Male | 6 | Fungal culture, PCR sequencing | Invasive Sinusitis | S. brasiliensis | S. brasiliensis | [102] | ||
Rio de Janeiro | 1 | Male | 56 | Fungal culture, PCR sequencing | Meningitis, Lymphocutaneous | S. brasiliensis | S. brasiliensis | [103] | ||
São Paulo | 20 from 2012–2020 | Male 9 (45%) |
Age ranged from 2–81 mean 32.2 ± 25.10 |
Fungal culture | ND | Sporothrix spp. | Sporothrix spp. | [104] | ||
Females 11 (55%) | ||||||||||
Rio de Janeiro | 64 from 2013–2015 | ND | Fungal culture (Sabouraud Dextrosa Agar, Mycosel ) | Lymphocutaneous 43 (67%) Fixed cutaneous 21 (33%) |
S. schenckii
sensu lato |
Sporothrix spp. | [105] | |||
Minas Gerais 1 Ceará 1 Goiás 1 Pernambuco2 São Paulo 1 |
6 | ND | Fungal culture (Potato Dextrose agar, Corn Meal agar), Carbohydrate assimilation tests, PCR sequiencing (calmodulin gene) | Lymphocutaneous 2 (33.3%) Disseminated 1 (16.7%) ND 3 (50%) |
Sporothrix mexicana 3 (50%) Sporothrix globosa 3 (50%) | Sporothrix mexicana 3 (50%) Sporothrix globosa 3 (50%) | [106] | |||
Colombia | Antioquia | 34 | ND | Fungal culture, PCR sequencing (ITS 1–2 and β-tubulin) | ND |
S. schenckii sensu stricto 22 (65.7%) S. globosa 12 (34.2%) |
S. schenckii 22 (65.7%) S. globosa 12 (34.3%) |
[56] | ||
Bogotá | 2.28% (14 cases/612 patients) |
Male ND Female ND |
Between: 0–18 | Fungal culture | ND | Sporothrix spp. | Sporothrix spp. | [107] | ||
Casanare | 1 | Male | 18 | Fungal culture, Histopathology | Verrucose | Sporothrix spp. | Sporothrix spp. | [108] | ||
Marandúa | 1 | Female | 48 | Fungal culture, Histopathology |
Fixed cutaneous | S. schenckii sensu lato | Sporothrix spp. | [109] | ||
Chile | Santiago | 1 | Male | 54 | Histopathology | Lymphocutaneous | Sporothrix spp. | Sporothrix spp. | [110] | |
Valparaíso | 1 | Female | 75 | Fungal culture Direct microscopy, Sugar assimilation (sucrose) |
Lymphocutaneous | Sporothrix globosa | Sporothrix globosa | [111] | ||
Viña del Mar | 1 | Female | 64 | Direct microscopy, Fungal culture (Sabouraud with cycloheximide and potato dextrose agar) nitrogen-based agar, sequencing (D1/D2 region of the fungal 26S rRNA gene, it region; a partial fragment of the β-tubulin gene; ITS 1 and 2; and the 5.8S gene (SU)). | Onychomycosis | Sporothrix pallida | Sporothrix pallida | [112] | ||
Paraguay | Itá | 2 | Male Male |
52 | Histopathology (Peryodic Acid Schiff), Fungal culture, direct microscopy with Giensa strein |
Lymphocutaneous 1 (50%) Fixed cutaneous 1 (50%) |
Sporothrix spp. | Sporothrix spp. | [113] | |
Cordillera 2 Guairá, Central 2 Misiones 2 San Pedro 2 Caaguazú 1 |
11 from 1997–2019. |
Male 10 Female 1 |
Mean Age: 37,6 ± 20 Range: 24–69 |
Direct microscopy (KOH 10%), fungal culture (Sabouraud agar with glucose 2%, potato dextrose agar with chloramphenicol), | Lymphocutaneous 11 (100%) |
Sporothrix schenckii complex | Sporothrix spp. | [114] | ||
Perú | Apurímac | 2 | Female | 65 | Direct microscopy, Giemsa stain Culture Microscopy with lactophenol cotton blue, Carbohydrate assimilation test (sucrose and raffinose) in nitrogen base |
Fixed cutaneous | S. schenckii | S. schenckii | [115] | |
Female | 67 | |||||||||
Apurímac | 21 | Male (12) Female (9) |
Average: 9 | Fungal culture | Lymphocutaneous 13 (62%) Fixed cutaneous 8 (38%) |
Sporothrix spp. | Sporothrix spp. | [116] | ||
Apurímac 2850 |
57 (15/100,000) |
Male 1734 Female 1255 |
ND | Fungal culture, Microscopy with lactophenol cotton blue and PCR sequencing |
Lymphocutaneous 2942 (63%) Fixed cutaneous 1728 (37%) |
S. schenckii 4651 (99.6%) S. schenckii sensu stricto 19 (0.4%) |
Sporothrix spp. 4651 (99.6%) S. schenckii 19 (0.4%) |
[117] | ||
Cajamarca 1500 |
30 (3/100,000) |
|||||||||
La Libertad 100 |
4 (0.5/100,000) |
|||||||||
Cusco 200 |
2 (0.2/100,000) |
|||||||||
Otras regiones 20 |
≤1 (0.1/100,000) | |||||||||
Abancay | 1 | Male | 6 | Fungal culture | Lymphocutaneous | Sporothrix spp. | Sporothrix spp. | [118] | ||
Lima | 1 | Male | 23 | Fungal Culture Microscopy with lactophenol blue, MALDI-TOF MS, PCR sequencing (D1/D2 region of the fungal 26S rRNA gene) |
Fixed cutaneous | S. schenckii | S. schenckii | [119] | ||
Lima | 1 | Male | 42 | Histopathology, Microscopy, Fungal Culture |
Disseminated cutaneous | S. schenkii sensu lato | Sporothrix spp. | [120] | ||
Cajamarca | 94 from 1991 to 2014 | Males (67) Female (27) |
Average: 36 | Direct microscopy, Gram and Giemsa stain, Fungal culture, Histopathology |
Lymphocutaneous 44 (47%) Fixed cutaneous 37 (39%) Disseminated cutaneous 11 (12%) Extra-cutaneous 1 (1%) ND 1 (1%) |
S. schenckii | Sporothrix spp. | [121] | ||
Apurímac | ||||||||||
Amazonas | ||||||||||
Ancash | 1 | Male | 58 | Fungal culture | Lymphocutaneous | S. schenckii | Sporothrix spp. | [122] | ||
Cusco | 1 | Female | 53 | Fungal culture (Sabouraud) | Disseminated | S. schenckii | Sporothrix spp. | [123] | ||
Uruguay | Tacuarembó 10 Cerro Largo 9 Canelones 9 Montevideo 5 Rocha 4 Paysandú 3 Flores 3 Río Negro 2 Colonia 2 Artigas 1 Rivera 1 Maldonado 1 Soriano 1 Non-registered 20 |
157 from 1983 to 2020 | Male (152) | 13–79 age range | Gram staining and culture in Sabouraud | Nodular Lymphatic 120 (76.4%) Fixed cutaneous 30 (19.1%) ND 7 (4.5%) |
Sporothrix spp. | Sporothrix spp. | [124] | |
Female (5) | ||||||||||
Venezuela | Caracas | 68 | ND | Fungal culture, PCR sequencing (Calmodulin locus and ITS regions) | ND |
S. schenckii 42 (62%) S. globosa 26 (38%) |
S. schenckii 42 (62%) S. globosa 26 (38%) |
[125] | ||
Aragua 55 Miranda 32 Other states 46 |
133 from 1963–2019 |
Male (95) Female (38) |
0–15 15–30 >30 |
Direct microscopy Fungal culture |
Lymphocutaneous 84 (63.15%) Fixed cutaneous 48 (36.09%) Cornea 1 (0.7%) |
S. schenckii sensu lato 130 (97.7%) ND 3 (2.3%) |
Sporothrix spp. | [126] | ||
Bolívar 14 | 0.55% (220 cases/39,806 patients) |
ND | 25–45 years | Microscopy and fungal culture | ND | Sporothrix spp. | Sporothrix spp. | [127] | ||
Caracas 160 | ||||||||||
Carabobo 6 | ||||||||||
Falcón 3 | ||||||||||
Lara 5 | ||||||||||
Mérida 1 | ||||||||||
Monagas 24 | ||||||||||
Sucre 1 | ||||||||||
Táchira 2 | ||||||||||
Zulia 4 | ||||||||||
Costal Range 22 | 31 from 1973–2013 | Male 64% Female 36% |
Microscopy, fungal culture, pruebas bioquímicas, PCR sequencing (Calmodulin gene and ITS 4–5) | Fixed cutaneous 18 (60%) Lymphocutaneous 11 (36.33%) Disseminated 1 (3.33)% |
S. schenckii sensu stricto 17 S. globosa 13 and Ophiostoma stenoceras 1 |
S. schenckii 17 (56.67%) S. globosa 13 (43.33%) |
[128] | |||
Andes 7 | ||||||||||
Plains 2 |
ND: Not Determined.
6. Discussion
A total of 124 publications were found with reports related to sporotrichosis in the Americas in the last 10 years, with 12,636 patients associated with infection caused by species of the genus Sporothrix. Interestingly, it was observed that 87.45% (11,050) of these cases were reported in South America, 11.55% (1460) in North America, and 1.00% (126) in Central America and the Caribbean [5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121,122,123,124,125,126,127,128]. The countries that presented the highest number of cases during the analyzed period were Brazil (5546—43.89%), Peru (4792—37.92%), and Mexico (1431—11.32%). It should be noted that in the case of Brazil and Peru, there were various reports with several cases from a time period ranging from 25 to 50 years [66,67,75,86]. As previously mentioned, sporotrichosis is a disease caused by a thermodymorphic fungus of the genus Sporothrix. It is known that this subcutaneous disease, although cosmopolitan, generally occurs in both tropical and subtropical regions. The latter could explain, in some part, the high prevalence in Latin America, being endemic in this region [1,2,3,4,129]. However, three countries (Brazil, Peru, and Mexico) have specific characteristics that increase the number of cases. In Brazil and adjacent countries (for example, Argentina and Paraguay), an increasing number of cases have been associated with zoonotic infection, mainly from infected cats through scratches or sneezes [3,4]. Since the zoonotic transmission of S. brasiliensis is the most important form of communication, it is recommended that hygienic measures be taken regarding domestic animals such as cats, rodents, etc., due to possible infections. If it is diagnosed in animals, it must be treated immediately, and gloves must be used when handling animals with injuries [2,3,4].
In Mexico, sporotrichosis is considered endemic and an occupational disease due to the different sources of infection. The climate of some regions in Mexico is perfect for the characteristics of this type of mycosis to increase its incidence. Although tropical and subtropical climates are preferred by this fungus, in this country, the cold and dry seasons are the contagion peaks of these pathological agents. The states that are more affected are Mexico City, Puebla, Jalisco, Michoacan, the State of Mexico, and Guanajuato. In these states, agriculture is one of the most important economic activities, which explains the high incidence of the Sporothrix contagion [130]. Thus, the principal recommendation in this region is the use of gloves or long-sleeved clothing when carrying out work activities where these species are endemic.
Regarding the etiological agents responsible for the types of sporotrichosis, it is important to specify that they were referred to both in the table and in the text in the way they were named in the articles that were analyzed. Since most of them were written and published before the changes in taxonomical classification, they do not consider the clinical and environmental clades classification instead of the Sporothrix schenckii complex.
As for the etiological agent of sporotrichosis, the most prevalent, according to the reports with the old taxonomical classification, were S. schenckii complex and Sporothrix spp. with 6624 cases (52.41%), S. schenckii with 5302 (41.95%), S. schenckii sensu lato with 245 (1.94%), S. schenckii sensu stricto with 147 (1.16%), S. brasiliensis with 153 (1.21%), S. globosa plus S. Schenckii sensu stricto with 91 (0.72%), S. globosa with 65 (0.51%), S. mexicana with 4 (0.03%), S. pallida 1 (0.008%), Ophiostoma stenoceras 1 (0.008%), and 4 ND cases (0.032%). It is worth mentioning that, although there are other species, such as Sporothrix luriei, there were no reports found in the studied period in the Americas [1,131].
Likewise, within the systematic review, Ophiostoma stenoceras appears, which in the taxonomic classification of Sporothrix is represented in its sexual state, in the year the report was made. Nevertheless, in 2016, Beer et al. concluded through phylogenetic analyzes that the genus Sporothrix was different from the genus Ophiostoma, but that was before considering its sexual state. Officially, the sexual status of Sporothrix is not known, and in this case, Ophiostoma stenoceras was included according to the regulations that governed the taxonomy before the divorce between the two genders occurred [132].
After analyzing the articles to carry out the classification according to the new taxonomy, we found that the most common reported etiological agent was Sporothrix spp. with 94.34% (11,922/12,636), followed by S. schenckii with 3.16% (400/12,636), S. brasiliensis with 1.21% (153/12,636), S. globosa plus S. schenckii with 0.72% (91/12,636), S. globosa with 0.51% (65/12,636), S. mexicana 0.03% (4/12,636), and S. pallida with 0.007% (1/12,636) [61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121,122,123,124,125,126,127,128].
On the other hand, the most frequent type of sporotrichosis was the lymphocutaneous with 4288 cases, followed by the fixed cutaneous with 2340 cases, the disseminated or systemic with 103, the disseminated cutaneous with 52 cases, other with 215 cases, and 5760 cases were ND. By being a subcutaneous mycosis, the lymphocutaneous form is the most frequent one because sporotrichosis mainly affects the lymph nodes of the skin and the subcutaneous tissue, producing ulcers and thereby affecting the lymphocutaneous system [133]. The infection begins in the form of an inoculation chancre. Subsequently, erythematous nodular lesions arise, which follow the trajectory of the lymphatic vessels, mainly affecting the face and upper and lower limbs. Another common form is the fixed cutaneous, which occupies the second place in the Americas to the present date. This type is of a fixed form at the inoculation site of the fungus, affecting mainly children, and it is observed as a verrucous plaque. Its presence demonstrates a high immunity response from the patient. Being a disease of this body region, it has a low prevalence in other organs or tissues. However, the disseminated or hematogenous form may be cutaneous or systemic [5,6,7,8]. Systemic sporotrichosis can cause respiratory and lung disorders, osteomyelitis, arthritis, and meningitis. It is important to note that the type of condition affecting the patients (5760 cases) was not mentioned in several of the reported cases analyzed in this publication.
Concerning diagnosis, various methods, both phenotypic and genotypic, have been used to detect the infection caused by this etiological agent [129]. Within the phenotypic methods, we can name (1) mycological cultures. This technique seeks the growth of the colony in a radial form (approximately 3 to 4 days) with a creamy consistency, and subsequently, the development of mycelium is observed for its identification (Gold Standard). Finally, it is suggested to perform a lactophenol blue staining to observe the microconidia in a sympodial arrangement along the mycelium. (2) serological diagnosis using sporotricine and immunodiffusion tests, immunoelectrophoresis, latex agglutination, etc. (3) histopathological diagnosis, an excisional biopsy of the nodular lesion is performed that may show granulomatous and necrotizing dermatitis, which can be stained with Hematoxylin and Eosin (HE) Schiff’s Periodic Acid (PAS), or Grocott-Gomori Methenamine Silver (MSG) to confirm the presence of asteroid bodies [5,6,7,8].
Nonetheless, genotypic identification tests are preferred since phenotypic techniques have disadvantages, such as being laborious, presenting variable results from the clinical field, and requiring many samples to reach a diagnosis. Therefore, different PCR techniques have been used for genotypic identification tests utilizing diverse genetic or molecular markers that have been developed [5].
In this systematic review, the culture turned out to be the most used diagnostic method throughout the continent, being performed in 107 of the 127 articles reviewed. Histopathological examination was the second most used diagnostic technique, found in 43 publications. In addition, PCR sequencing was used 38 times, direct microscopy 21 times, and microscopy with lactophenol blue was reported in 9 articles. Lastly, other techniques were used to detect sporotrichosis; however, these were not utilized routinely.
Author Contributions
R.H.-C., R.P.-A., R.A. and E.M.-H. designed the study and wrote the manuscript, contributing equally to the accomplishment of the work; R.P.-A., C.R.-C., C.D.S.-C., V.M.E.-H. and E.R.J.-D. contributed to the writing of the manuscript; K.Y.S.-M., E.M.-H., C.R.-C., E.C.-C., J.X.-C. and E.M.C.-C. planned, extracted data, wrote, and critically reviewed the manuscript; R.H-C., J.S.-V., C.R.-C. and E.M.-H. wrote and critically reviewed the manuscript. All authors have read and agreed to the published version of the manuscript.
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Data Availability Statement
Not applicable.
Conflicts of Interest
The authors declare no conflict of interest.
Funding Statement
This research received no external funding.
Footnotes
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Lopes-Bezerra L.M., Mora-Montes H.M., Zhang Y., Nino-Vega G., Rodrigues A.M., de Camargo Z.P., de Hoog S. Sporotrichosis between 1898 and 2017: The evolution of knowledge on a changeable disease and on emerging etiological agents. Med. Mycol. 2018;56:S126–S143. doi: 10.1093/mmy/myx103. [DOI] [PubMed] [Google Scholar]
- 2.Rabello V.B.S., Almeida M.A., Bernardes-Engemann A.R., Almeida-Paes R., de Macedo P.M., Zancopé-Oliveira R.M. The Historical Burden of Sporotrichosis in Brazil: A Systematic Review of Cases Reported from 1907 to 2020. Braz. J. Microbiol. 2022;53:231–244. doi: 10.1007/s42770-021-00658-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Rodrigues A.M., Della Terra P.P., Gremião I.D., Pereira S.A., Orofino-Costa R., de Camargo Z.P. The threat of emerging and re-emerging pathogenic Sporothrix species. Mycopathologia. 2020;185:813–842. doi: 10.1007/s11046-020-00425-0. [DOI] [PubMed] [Google Scholar]
- 4.Gremião I.D.F., Evangelista Oliveira M.M., Monteiro de Miranda L.H., Saraiva Freitas D.F., Peraira S.A. Geographic Expansion of Sporotrichosis, Brazil. Emergy Infect. Dis. 2020;26:621–662. doi: 10.3201/eid2603.190803. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Bunce P.E., Yang L., Chun S., Zhang S.X., Trinkaus M.A., Matukas L.M. Disseminated sporotrichosis in a patient with hairy cell leukemia treated with amphotericin B and posaconazole. Med. Mycol. 2012;50:197–201. doi: 10.3109/13693786.2011.584074. [DOI] [PubMed] [Google Scholar]
- 6.Tai F., Jakubovic H., Alabdulrazzaq S., Alavi A. A case of sporotrichosis infection mimicking pyoderma gangrenosum and the role of tissue culture in diagnosis: A case report. SAGE Open Med. Case Rep. 2020;8:2050313X20919600. doi: 10.1177/2050313X20919600. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Hayfron K., Wiedeman J.A. A 7-year-old girl with ulcerative lesion after a rodent bite. Pediatr. Infect. Dis. J. 2010;29:185–193. doi: 10.1097/INF.0b013e3181be6243. [DOI] [PubMed] [Google Scholar]
- 8.Kamal A., Orenstein R. Disseminated sporotrichosis. J. Hosp. Med. 2010;5:E29–E30. doi: 10.1002/jhm.472. [DOI] [PubMed] [Google Scholar]
- 9.Lyengar S.S., Khan J.A., Brusco M., FitzSimmons C.J. Cutaneous Sporothrix schenckii of the human eyelid. Ophthalmic Plast. Reconstr. Surg. 2010;26:305–306. doi: 10.1097/IOP.0b013e3181c15c1f. [DOI] [PubMed] [Google Scholar]
- 10.Milby A.H., Pappas N.D., O’Donnell J., Bozentka D.J. Sporotrichosis of the upper extremity. Orthopedics. 2010;33:1–3. doi: 10.3928/01477447-20100225-27. [DOI] [PubMed] [Google Scholar]
- 11.Assi M., Lakkis I.E., Wheat L.J. Cross-reactivity in the Histoplasma antigen enzyme immunoassay caused by sporotrichosis. Clin. Vaccine Immunol. 2011;18:1781–1782. doi: 10.1128/CVI.05017-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Parekh P.K., Butler D.F. What is your diagnosis? Periorbital granulomatous plaque. Pediatr. Dermatol. 2011;28:457–458. doi: 10.1111/j.1525-1470.2011.01499.x. [DOI] [PubMed] [Google Scholar]
- 13.Rees R.K., Swartzberg J.E. Feline-transmitted sporotrichosis: A case study from California. Dermatol. Online. J. 2011;17:2. doi: 10.5070/D30459K1JB. [DOI] [PubMed] [Google Scholar]
- 14.Sharon V.R., Kim J., Sudhakar S., Fung M.A., Maniar A. Disseminated cutaneous sporotrichosis. Lancet Infect. Dis. 2013;13:95. doi: 10.1016/S1473-3099(12)70140-8. [DOI] [PubMed] [Google Scholar]
- 15.Adnan M.M., Fierro-Fine A., Zhao L., Khalil M.O. Metastic melanoma masquerading as disseminated sporotrichosis. J. Community Support. Oncol. 2014;12:339–340. doi: 10.12788/jcso.0074. [DOI] [PubMed] [Google Scholar]
- 16.Trotter J.R., Sriaroon P., Berman D., Petrovic A., Leiding J.W. Sporothrix schenckii lymphadentitis in a male with X-linked chronic granulomatous disease. J. Clin. Immunol. 2014;34:49–52. doi: 10.1007/s10875-013-9968-0. [DOI] [PubMed] [Google Scholar]
- 17.Bahr N.C., Janssen K., Billings J., Loor G., Green J.S. Respiratory failure due to possible donor-derived Sporothrix schenckii infection in a lung transplant recipient. Case Rep. Infect. Dis. 2015;2015:925718. doi: 10.1155/2015/925718. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Hassan K., Turker T., Zangeneh T. Disseminated sporotrichosis in an immunocompetent patient. Case Rep. Plast. Surg. Hand Surg. 2016;3:44–47. doi: 10.3109/23320885.2016.1168703. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Lederer H.T., Sullivan E., Crum-Cianflone N.F. Sporotrichosis as an unusual case of osteomyelitis: A case report and review of the literature. Med. Mycol. Case Rep. 2016;11:31–35. doi: 10.1016/j.mmcr.2016.04.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Aronowitz P.B., Gilroy M., Christiansen K.N. Disseminated Sporotrichosis with Osteolytic Bone Involvement. J. Gen. Intern. Med. 2017;32:1063. doi: 10.1007/s11606-017-4048-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Charles K., Lowe L., Shuman E., Cha K.B. Painful linear ulcers: A case of cutaneous sporotrichosis mimicking pyoderma gangrenosum. JAAD Case Rep. 2017;3:519–552. doi: 10.1016/j.jdcr.2017.07.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Hessler C., Kauffman C.A., Chow F.C. The upside of bias: A case of chronic meningitis due to Sporothrix schenckii in an immunocompetent host. Neurohospitalist. 2017;7:30–34. doi: 10.1177/1941874416641468. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Barbaryan A., El Atrouni W., Bailuc S., Jones M.W., Bhakta M., Mahmoud K.H., Mirrakhimov A.E. Isolated Sporothrix schenckii monoarthritis. Case Rep. Infect. Dis. 2018;2018:9037657. doi: 10.1155/2018/9037657. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Farooqui S.M., Youness H. The Infection Returns: A case of pulmonary sporotrichosis relapse after chemotherapy. Case Rep. Med. 2018;2018:1384029. doi: 10.1155/2018/1384029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Patel R., Busby L.P., Motamedi D. Delayed diagnosis in a case of smoldering sporotrichal monoarthropathy. J. Radiol. Case Rep. 2019;13:17–23. doi: 10.3941/jrcr.v13i1.3520. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Saeed L., Weber R.J., Puryear S.B., Bahrani E., Peluso M.J., Babik J.M., Haemel A., Coates S.J. Disseminated cutaneous and osteoarticular sporotrichosis mimicking pyoderma gangrenosum. Open Forum Infect. Dis. 2019;6:ofz395. doi: 10.1093/ofid/ofz395. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.White M., Adams L., Phan C., Erdag G., Totten M., Lee R., Lu X., Mehta S., Miller L.S., Zhang S.X. Disseminated sporotrichosis following iatrogenic immunosuppression for suspected pyoderma gangrenosum. Lancet Infect. Dis. 2019;19:e385–e391. doi: 10.1016/S1473-3099(19)30421-9. [DOI] [PubMed] [Google Scholar]
- 28.Kaadan M.I., Dennis M., Desai N., Yadavalli G., Lederer P. One health education for future physicians: A case report of cat-transmitted sporotrichosis. Open Forum Infect. Dis. 2020;7:ofaa049. doi: 10.1093/ofid/ofaa049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Parker N., Strong N., Pichetsurnthorn P., Lalich D., Moore T. Disseminated sporotrichosis with brain abscesses in an HIV-Infected patient. Cureus. 2020;12:e8016. doi: 10.7759/cureus.8016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Shah D., Kim A.E., Elbadri S., Desai B., Ganti L. An uncommon rash in the emergency department: Sporothrix Schenckii. Cureus. 2021;13:e16125. doi: 10.7759/cureus.16125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Wellington T., Hauschild J., Krauland K.J., Verwiebe E.G., Markelz A.E. Sporotrichosis in a U.S. Army basic trainee. Mil. Med. 2021:usab463. doi: 10.1093/milmed/usab463. [DOI] [PubMed] [Google Scholar]
- 32.Zambrano A.I., Church E.C., McKay K.M., Carnes S.K., Morse R.J., Leveque T.K., Roxby A.C. A disfiguring rash. Open Forum Infect. Dis. 2021;8:ofab332. doi: 10.1093/ofid/ofab332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Kenny H., Dougherty M., Churnin I., Early S., Gupta A., McGarey P.O., Jr. Chronic laryngotracheal granulomatous disease secondary to Sporothrix schenckii in an immunocompromised patient. Ann. Otol. Rhinol. Laryngol. 2022:34894211073002. doi: 10.1177/00034894211073002. [DOI] [PubMed] [Google Scholar]
- 34.Gutierrez-Morales J.L., Domínguez Romero R., Morales Esponda M., Rossiere Echazaleta N.L., Reyes Bonifant G., Santos Ramírez A. Esporotricosis micematoide con invasión a médula espinal. Rev. Mex. Neuroci. 2011;12:50–54. [Google Scholar]
- 35.Romero-Cabello R., Bonifaz A., Romero-Feregrino R., Sánchez C.J., Linares Y., Zavala J.T., Romero L.C., Romero-Feregrino R., Vega J.T. Disseminated sporotrichosis. BMJ Case Rep. 2011;2011:bcr1020103404. doi: 10.1136/bcr.10.2010.3404. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Rojas-Padilla R., Pastrana R., Toledo M., Valencia A., Mena C., Bonifaz A. Esporotricosis cutánea linfangítica por mordedura de araña. Dermatol. Rev. Mex. 2013;57:479–484. [Google Scholar]
- 37.Espinoza-Hernández C.J., Jesús-Silva A., Toussaint-Caire S., Arenas R. Disseminated sporotrichosis with cutaneous and testicular involvement. Actas Dermosifiliogr. 2014;105:204–206. doi: 10.1016/j.ad.2013.02.002. [DOI] [PubMed] [Google Scholar]
- 38.Chávez-López G., Estrada-Castañón R., Estrada-Chávez G., Vega-Memije M.E., Moreno-Coutiño G. Esporotricosis cutánea diseminada: Un caso de la región de la montaña del estado de Guerrero, México. Dermatol. Rev. Mex. 2015;59:228–232. [Google Scholar]
- 39.Cotino Sánchez A., Torres-Alvarez B., Gurrola Morales T., Méndez Martínez S., Saucedo Gárate M., Castanedo-Cazares J.P. Mycosis fungoides-like lesions in a patient with diffuse cutaneous sporotrichosis. Rev. Iberoam. Micol. 2015;32:200–203. doi: 10.1016/j.riam.2014.06.009. [DOI] [PubMed] [Google Scholar]
- 40.Bonifaz A., Tirado-Sánchez A., Paredes-Solís V., Cepeda-Valdés R., González G.M., Treviño-Rangel R.J., Fierro-Arias L. Cutaneous disseminated sporotrichosis: Clinical experience of 24 cases. J. Eur. Acad. Dermatol. Venereol. 2018;32:e77–e79. doi: 10.1111/jdv.14533. [DOI] [PubMed] [Google Scholar]
- 41.Bonifaz A., Toriello C., Araiza J., Ramírez-Soto M.C., Tirado-Sánchez A. Sporotrichin skin test for the diagnosis of sporotrichosis. J. Fungi. 2018;4:55. doi: 10.3390/jof4020055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Estrada-Castañón R., Chávez-López G., Estrada-Chávez G., Bonifaz A. Report of 73 cases of cutaneous sporotrichosis in Mexico. An. Bras. Dermatol. 2018;93:907–909. doi: 10.1590/abd1806-4841.20187726. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Ochoa-Reyes J., Ramos-Martínez E., Treviño-Rangel R., González G.M., Bonifaz A. Auricular sporotrichosis. Atypical case report simulating bacterial cellulitis. Rev. Chil. Infectol. 2018;35:83–87. doi: 10.4067/s0716-10182018000100083. [DOI] [PubMed] [Google Scholar]
- 44.Puebla-Miranda M., Vásquez-Ramírez M., González-Ibarra M., Torres-López I.H. Esporotricosis. Reporte de un caso ocupacional. Rev. Hosp. Jua. Mex. 2018;85:246–250. [Google Scholar]
- 45.Rangel-Gamboa L., Martinez-Hernandez F., Maravilla P., Flisser A. A population genetics analysis in clinical isolates of Sporothrix schenckii based on calmodulin and calcium/calmodulin-dependent kinase partial gene sequences. Mycoses. 2018;61:383–392. doi: 10.1111/myc.12751. [DOI] [PubMed] [Google Scholar]
- 46.Rojas O.C., Bonifaz A., Campos C., Treviño-Rangel R.J., González-Álvarez R., González G.M. Molecular identification, antifungal susceptibility, and geographic origin of clinical Strains of Sporothrix schenckii complex in Mexico. J. Fungi. 2018;4:86. doi: 10.3390/jof4030086. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Estrada-Castañón R., Estrada-Chávez G., Chávez-López M.G. Diagnosis and management of fungal neglected tropical diseases in community settings-mycetoma and sporotrichosis. Trop. Med. Infect. Dis. 2019;4:81. doi: 10.3390/tropicalmed4020081. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Mayorga-Rodríguez J., Mayorga-Garibaldi J.L., Muñoz-Estrada V.F., De León Ramírez R.M. Esporotricosis: Serie de 1134 casos en una zona endémica de México. Med. Cut. Ibero Lat. Am. 2019;47:24–28. [Google Scholar]
- 49.Alvarez-Rivero V., Hernandez-Castro R., Moreno-Coutiño G., Lozano-Platonoff A. Disseminated sporotrichosis: An important differential diagnosis for venous ulcers. Adv. Skin. Wound Care. 2020;33:1–3. doi: 10.1097/01.ASW.0000666908.88965.35. [DOI] [PubMed] [Google Scholar]
- 50.Bonifaz A., Morales-Peña N., Tirado-Sánchez A., Jiménez-Mendoza D.R., Treviño-Rangel R.J., González G.M. Atypical sporotrichosis related to Sporothrix mexicana. Mycopathologia. 2020;185:733–735. doi: 10.1007/s11046-020-00463-8. [DOI] [PubMed] [Google Scholar]
- 51.Bonifaz A., Tirado-Sánchez A., Araiza J., Treviño-Rangel R., González G.M. Deep mycoses and pseudomycoses of the foot: A single-center retrospective study of 160 cases, in a tertiary-care center in Mexico. Foot. 2021;46:101770. doi: 10.1016/j.foot.2020.101770. [DOI] [PubMed] [Google Scholar]
- 52.Martínez-Herrera E., Arenas R., Hernández-Castro R., Frías-De-León M.G., Rodríguez-Cerdeira C. Uncommon clinical presentations of sporotrichosis: A two-case report. Pathogens. 2021;10:1249. doi: 10.3390/pathogens10101249. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Lozada-Alvarado S., Salas-Campos I., Uribe-Lorío L., Gross N.T. Molecular and Biochemical Identification and In Vitro Susceptibility to Itraconazole of Costa Rican Clinical Isolates of the Sporothrix schenckii Complex. Acta Sci. Microbiol. 2020;3:116–123. doi: 10.31080/ASMI.2020.03.0737. [DOI] [Google Scholar]
- 54.Román-Carrillo M., Porres-Paredes S., Orozco R., Argueta V. Cutaneous Sporotrichosis. Case report. Rev. Médica Gt Colmedegua. 2018;157:90–92. [Google Scholar]
- 55.Sánchez-Cárdenas C.D., Porras-López C., Morales-Ezquivel O., Frías-De-León M.G., Juárez-Durán E.R., Arenas R., Martínez-Herrera E. Sporotrichosis: Epidemiological, clinical and mycological study of 53 cases in Guatemala. Life Sci. Press. 2018;2:66–69. doi: 10.28964/LifesciPress-2-110. [DOI] [Google Scholar]
- 56.Flórez-Muñoz S.V., Alzate J.F., Mesa-Arango A.C. Molecular Identification and Antifungal Susceptibility of Clinical Isolates of Sporothrix schenckii Complex in Medellin, Colombia. Mycopathologia. 2019;184:53–63. doi: 10.1007/s11046-018-0310-5. [DOI] [PubMed] [Google Scholar]
- 57.Medina R., Flores J., Luque M.T. Sporotrichosis in an Adolescent Patient. Honduras Pediátrica. 2021;34:32–33. doi: 10.5377/hp.v34i1.12857. [DOI] [Google Scholar]
- 58.Rios M.E., Suarez M.D., Moreno J., Vallee J., Moreno J.P. Zoonotic Sporotrichosis Related to Cat Contact: First Case Report from Panama in Central America. Cureus. 2018;10:e2906. doi: 10.7759/cureus.2906. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Fernandez M.C., Reyes N., Gonzalez J.C., Montesino M., Apaulasa K. Sporotrichosis. A propos of a case. Rev. Cubana Med. Trop. 2016;68:171–178. [Google Scholar]
- 60.Pérez-Morales L., Iglesias-López M., Quiñones-Cherta O., Reyes-Rodríguez I. Microbiological Isolation of Sporothrix Schenckii in an Immunocompromised Patient. A Case Report. Rev. Cienc. Médicas Cienfuegos. 2014;12:662–669. [Google Scholar]
- 61.Rojas F.D., Fernández M.S., Lucchelli J.M., Lombardi D., Malet J., Vetrisano M.E., Cattana M.E., de los Ángeles Sosa M., Giusiano G. Cavitary Pulmonary Sporotrichosis: Case Report and Literature Review. Mycopathologia. 2017;182:1119–1123. doi: 10.1007/s11046-017-0197-6. [DOI] [PubMed] [Google Scholar]
- 62.Etchecopaz A., Toscanini M.A., Gisbert A., Mas J., Scarpa M., Iovannitti C.A., Bendezú K., Nusblat A.D., Iachini R., Cuestas M.L. Sporothrix brasiliensis: A review of an emerging south american fungal pathogen, its related disease, presentation and spread in Argentina. J. Fungi. 2021;7:170. doi: 10.3390/jof7030170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Córdoba S., Isla G., Szusz W., Vivot W., Hevia A., Davel G., Canteros C.E. Molecular identification and susceptibility profile of Sporothrix schenckii sensu lato isolated in Argentina. Mycoses. 2018;61:441–448. doi: 10.1111/myc.12760. [DOI] [PubMed] [Google Scholar]
- 64.Picollo M., Epelbaum C., Bustos A.C., Carnovale S., Rosanova M.T. Lymphocutaneous sporotrichosis in a pediatric patient, a case report. Rev. Chil. Infectol. 2021;38:811–815. doi: 10.4067/s0716-10182021000600811. [DOI] [PubMed] [Google Scholar]
- 65.Alzuguir C.L.C., Pereira S.A., Magalhães M.A.F.M., Almeida-Paes R., Freitas D.F.S., Oliveira L.F.A., Pimentel M.I.F. Geo-epidemiology and socioeconomic aspects of human sporotrichosis in the municipality of Duque de Caxias, Rio de Janeiro, Brazil, between 2007 and 2016. Trans. R. Soc. Trop. Med. Hyg. 2020;114:99–106. doi: 10.1093/trstmh/trz081. [DOI] [PubMed] [Google Scholar]
- 66.Almeida-Paes R., de Oliveira M.M.E., Freitas D.F.S., do Valle A.C.F., Zancopé-Oliveira R.M., Gutierrez-Galhardo M.C. Sporotrichosis in Rio de Janeiro, Brazil: Sporothrix brasiliensis Is Associated with Atypical Clinical Presentations. PLoS Negl. Trop. Dis. 2014;8:e309. doi: 10.1371/journal.pntd.0003094. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Freitas D.F.S., do Valle A.C.F., da Silva M.B.T., Campos D.P., Lyra M.R., De Souza R.V., Veloso V.G., Zancopé-Oliveira R.M., Bastos F.I., Galhardo M.C.G. Sporotrichosis: An Emerging Neglected Opportunistic Infection in HIV-Infected Patients in Rio de Janeiro, Brazil. PLoS Negl. Trop. Dis. 2014;8:e3110. doi: 10.1371/journal.pntd.0003110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Freitas D.F.S., de Siqueira Hoagland B., do Valle A.C.F., Fraga B.B., de Barros M.B., de Oliveira Schubach A., de Almeida-Paes R., Cuzzi T., Rosalino C.M.V., Zancopé-Oliveira R.M., et al. Sporotrichosis in HIV-infected patients: Report of 21 cases of endemic sporotrichosis in Rio de Janeiro, Brazil. Med. Mycol. 2012;50:170–178. doi: 10.3109/13693786.2011.596288. [DOI] [PubMed] [Google Scholar]
- 69.Arinelli A., Aleixo A.L.Q.D.C., Freitas D.F.S., Valle A.C.F.D., Almeida-Paes R., Gutierrez-Galhardo M.C., Curi A.L.L. Ocular Sporotrichosis: 26 Cases with Bulbar Involvement in a Hyperendemic Area of Zoonotic Transmission. Ocul. Immunol. Inflamm. 2020;28:764–771. doi: 10.1080/09273948.2019.1624779. [DOI] [PubMed] [Google Scholar]
- 70.Pereira M.A., Freitas R.J., Nascimento S.B., Pantaleão L., Vilar E.G. Sporotrichosis: A Clinicopathologic Study of 89 Consecutive Cases, Literature Review, and New Insights About Their Differential Diagnosis. Am. J. Dermatopathol. 2020;42:751–755. doi: 10.1097/DAD.0000000000001617. [DOI] [PubMed] [Google Scholar]
- 71.Rocha I.D.C.B., Della Terra P.P., de Oliveira R.C., Zanotti R.L., Falqueto A., de Camargo Z.P., Rodrigues A.M., Goncalves S.S. Molecular-based assessment of diversity and population structure of Sporothrix spp. clinical isolates from Espírito Santo-Brazil. Mycoses. 2021;64:420–427. doi: 10.1111/myc.13230. [DOI] [PubMed] [Google Scholar]
- 72.Caus A.L.O., Zanotti R.L., Faccini-Martínez Á.A., Paterlini G.V., Falqueto A. Epidemiological and clinical aspects of sporotrichosis in Espírito Santo State, southeast Brazil: A study of three decades (1982–2012) Am. J. Trop. Med. Hyg. 2019;100:706–713. doi: 10.4269/ajtmh.18-0667. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Poester V.R., Mattei A.S., Madrid I.M., Pereira J.T.B., Klafke G.B., Sanchotene K.O., Brandolt T.M., Xavier M.O. Sporotrichosis in Southern Brazil, towards an epidemic? Zoonoses Public Health. 2018;65:815–821. doi: 10.1111/zph.12504. [DOI] [PubMed] [Google Scholar]
- 74.Benvegnú A.M., Dallazzem L.N.D., Chemello R.M.L., Beber A.A.C., Chemello D. Case series of sporotrichosis at a teaching hospital in Brazil. Rev. Soc. Bras. Med. Trop. 2020;53:e20190509. doi: 10.1590/0037-8682-0509-2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Grisolia J.C., Santos L.A., Coelho L.M.L., Silva R.R., de Camargo Z.P., Velloso T.R.G., Coelho L.F., Chavasco J.K., Malaquias L.C.C. Seroepidemiological survey on sporotrichosis-infection in rural areas of the south of Minas Gerais State, Brazil. Braz. J. Microbiol. 2021;52:41–47. doi: 10.1007/s42770-020-00279-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Filho J.E., dos Santos I.B., Reis C.M.S., Patané J.S.L., Paredes V., Bernardes J.P.R.A., Poggiani S.D.S.C., Castro T.D.C.B., Gomez O.M., Pereira S.A., et al. A novel Sporothrix brasiliensis genomic variant in Midwestern Brazil: Evidence for an older and wider sporotrichosis epidemic. Emerg. Microbes Infect. 2020;9:2515–2525. doi: 10.1080/22221751.2020.1847001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Marques G.F., Martins A.L.G.P., Sousa J.M.P., Brandão L.S.G., Wachholz P.A., Masuda P.Y. Characterization of sporotrichosis cases treated in a dermatologic teaching unit in the State of São Paulo-Brazil, 2003–2013. Bras. Dermatol. 2015;90:273–275. doi: 10.1590/abd1806-4841.20153447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Veasey J., Neto M., Ruiz L., Zaitz C. Clinical and laboratory profile of urban sporotrichosis in a tertiary hospital in the city of São Paulo. Bras. Dermatol. 2021;96:243–245. doi: 10.1016/j.abd.2020.07.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Ferreira L.C., Barroso P.F., Tonomura E., Akiti T., Rodrigues K.M. Osteomyelitis caused by Sporothrix schenckii in an immunocompetent patient. Rev. Soc. Bras. Med. Trop. 2016;49:527–529. doi: 10.1590/0037-8682-0354-2015. [DOI] [PubMed] [Google Scholar]
- 80.Matos A.M.F., Moreira L.M., Barczewski B.F., De Matos L.X., De Oliveira J.B.V., Pimentel M.I.F., Almeida-Paes R., Oliveira M.G., Pinto T.C.A., Lima N., et al. Identification by MALDI-TOF MS of Sporothrix brasiliensis Isolated from a Subconjunctival Infiltrative Lesion in an Immunocompetent Patient. Microorganisms. 2020;8:22. doi: 10.3390/microorganisms8010022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.do Monte Alves M., Pipolo Milan E., da Silva-Rocha W.P., Soares de Sena da Costa A., Araújo Maciel B., Cavalcante Vale P.H., de Albuquerque P.R., Lopes Lima S., Salles de Azevedo Melo A., Messias Rodrigues A., et al. Fatal pulmonary sporotrichosis caused by Sporothrix brasiliensis in Northeast Brazil. PLoS Negl. Trop. Dis. 2020;14:e0008141. doi: 10.1371/journal.pntd.0008141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Xavier J.R.B., Waller S.B., Osório L.D.G., Vives P.S., Albano A.P.N., de Aguiar E.S.V., Ferreira M.R.A., da Conceição F.R., de Faria R.O., Meireles M.C.A., et al. Human sporotrichosis outbreak caused by Sporothrix brasiliensis in a veterinary hospital in Southern Brazil. J. Mycol. Med. 2021;31:101163. doi: 10.1016/j.mycmed.2021.101163. [DOI] [PubMed] [Google Scholar]
- 83.de Sá Menezes Carvalho G., Verrinder Veasey J. Immunoreactive cutaneous sporotrichosis. Bras. Dermatol. 2020;95:737–739. doi: 10.1016/j.abd.2019.11.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Lacerda Filho A.M., Cavalcante C.M., Da Silva A.B., Inácio C.P., de Lima-Neto R.G., De Andrade M.C.L., Magalhães O.M.C., Dos Santos F.D.A.G., Neves R.P. High-Virulence Cat-Transmitted Ocular Sporotrichosis. Mycopathologia. 2019;184:547–549. doi: 10.1007/s11046-019-00347-6. [DOI] [PubMed] [Google Scholar]
- 85.de Moura Barros N., de Souza Pessoa A., Martins Brotas A. Systemic sporotrichosis in an alcoholic patient. Bras. Dermatol. 2020;95:376–378. doi: 10.1016/j.abd.2019.08.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Lemes L.R., Veasey J.V., Soutto-Mayor S., Contin-Proenca C. Ocular involvement in sporotrichosis: Report of two cases in children. Bras. Derm. 2021;96:349–351. doi: 10.1016/j.abd.2020.08.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Henckens N.F.T., Rovers J.F.J., van Dommelen L., Bovenschen H.J. Can cats cause colossal contagious cutaneous carbuncles? Derm. Online J. 2021;27 doi: 10.5070/D3274053162. [DOI] [PubMed] [Google Scholar]
- 88.Lora Barraza L., Bissoli Tolomelli J., Graça Cunha C., Bernardes Filho F., Towersey L., Hay R., Casz Schechtman R., da Costa Nery J.A. Facial Cutaneous Sporotrichosis in a Boy. J. Emerg. Med. 2019;56:222–223. doi: 10.1016/j.jemermed.2018.10.031. [DOI] [PubMed] [Google Scholar]
- 89.de Freitas Valente M., Bertazzoli Diogo A., Culau Merlo V.F., Pereira Pegas J.R. Disseminated cutaneous sporotrichosis: Unusual presentation in an alcoholic patient. Rev. Inst. Med. Trop. São Paulo. 2020;62:e60. doi: 10.1590/s1678-9946202062060. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Crestani L., de Castro e Souza B., Kakizaki P., Sakai-Valente N.Y. Therapeutic failure with itraconazole in sporotrichosis due to bariatric surgery. Bras. Derm. 2020;95:241–243. doi: 10.1016/j.abd.2019.04.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Arantes-Ferreira G.S., Watanabe A.L.C., Trevizoli N.C., Jorge F.M.F., Cajá G.O.N., Diaz L.G.G., Meireles L.P., Araújo M.C.C.L. Disseminated Sporotrichosis in a Liver Transplant Patient: A Case Report. Transpl. Proc. 2019;51:1621–1624. doi: 10.1016/j.transproceed.2019.02.019. [DOI] [PubMed] [Google Scholar]
- 92.Fichman V., Valle A.C.F.D., de Macedo P.M., Freitas D.F.S., Oliveira M.M.E., Almeida-Paes R., Gutierrez-Galhardo M.C. Cryosurgery for the treatment of cutaneous sporotrichosis in four pregnant women. PLoS Negl. Trop. Dis. 2018;12:e0006434. doi: 10.1371/journal.pntd.0006434. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Biancardi A.L., Freitas D.F., Vitor R.D., Andrade H.B., de Oliveira M.M., do Valle A.C., Zancope-Oliveira R.M., Galhardo M.C., Curi A.L. Multifocal choroiditis in disseminated sporotrichosis in patients with HIV/AIDS. Retin. Cases Brief Rep. 2017;11:67–70. doi: 10.1097/ICB.0000000000000290. [DOI] [PubMed] [Google Scholar]
- 94.Fischman-Gompertz O., Rodrigues A.M., Fernandes G.F., Bentubo H.D.L., Pires de Camargo Z., Petri V. Atypical Clinical Presentation of Sporotrichosis Caused by Sporothrix globosa Resistant to Itraconazole. Am. J. Trop. Med. Hyg. 2016;94:1218–1222. doi: 10.4269/ajtmh.15-0267. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Aparecida-Grazziotin N., Gonçalves I.L., Todeschini D., Grazziotin-Vedana L., Canello-Todeschini C.M., Grazziotin C. Squamous cell carcinoma subsequent to scarring caused by sporotrichosis: A case report. Rev. Iberoam. Micol. 2019;36:83–85. doi: 10.1016/j.riam.2018.10.002. [DOI] [PubMed] [Google Scholar]
- 96.Ribeiro B.N., Ribeiro R.N., Penna C.R., Frota A.C. Bone involvement by Sporothrix schenckii in an immunocompetent child. Pediatr. Radiol. 2015;45:1427–3140. doi: 10.1007/s00247-015-3299-7. [DOI] [PubMed] [Google Scholar]
- 97.Freitas D.F., Santos S.S., Almeida-Paes R., de Oliveira M.M., do Valle A.C., Gutierrez-Galhardo M.C., Zancopé-Oliveira R.M., Nosanchuk J.D. Increase in virulence of Sporothrix brasiliensis over five years in a patient with chronic disseminated sporotrichosis. Virulence. 2015;6:112–120. doi: 10.1080/21505594.2015.1014274. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Nassif P.W., Granado I.R., Ferraz J.S., Souza R., Nassif A.E. Atypical presentation of cutaneous sporotrichosis in an alcoholic patient. Dermatol. Online J. 2012;18:12. [PubMed] [Google Scholar]
- 99.Falqueto A., Bravim-Maifrede S., Araujo-Ribeiro M. Unusual clinical presentation of sporotrichosis in three members of one family. Intern. J. Dermatol. 2012;51:434–438. doi: 10.1111/j.1365-4632.2011.5085.x. [DOI] [PubMed] [Google Scholar]
- 100.Marques-de-Macedo P., Sztajnbok D.C.N., Camargo Z.P., Rodrigues A.M., Lopes-Bezerra L.M., Bernardes-Engemann A.R., Orofino-Costa R. Dacryocystitis due to Sporothrix brasiliensis: A case report of a successful clinical and serological outcome with low-dose potassium iodide treatment and oculoplastic surgery. Br. J. Dermatol. 2015;172:1116–1119. doi: 10.1111/bjd.13378. [DOI] [PubMed] [Google Scholar]
- 101.Fichman V., Saraiva-Freitas D.F., Marques-de-Macedo P., Francesconi-do-Valle A.C., Almeida-Silva F., Zancopé-Oliveira R.M., Almeida-Paes R., Gutierrez-Galhardo M.C. Sporotrichosis After Tattooing Caused by Sporothrix. Bras. Mycopathol. 2022;187:137–139. doi: 10.1007/s11046-021-00611-8. [DOI] [PubMed] [Google Scholar]
- 102.Nepomuceno Araújo M.J.C.L., Nihei C.H., Rodrigues A.M., Higashino H., Ponzio V., Campos Pignatari A.C., Barcellos M.A., Braga O., Duayer I.F. Case Report: Invasive Sinusitis due to Sporothrix Brasiliensis in a Renal Transplant Recipient. Am. J. Trop. Med. Hyg. 2021;105:1218–1221. doi: 10.4269/ajtmh.20-1602. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Lima M.A., Vallier R., Silva M.M. Sporothrix brasiliensis meningitis in an immunocompetent patient. Pract. Neurol. 2021;21:241–242. doi: 10.1136/practneurol-2020-002915. [DOI] [PubMed] [Google Scholar]
- 104.Veasey J.V., Carvalho G.S.M., Ruiz L.R.B., Neves-Neto M.F., Zaitz C. Epidemiological and geographical distribution profile of urban sporotrichosis in the city of São Paulo. Bras. Derm. 2022;97:228–230. doi: 10.1016/j.abd.2020.11.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Antonio L.D.F., Pimentel M.I.F., Lyra M.R., Madeira M.D.F., Miranda L.D.F.C., Paes R.A., Brito-Santos F., Carvalho M.H.G.F., Schubach A.D.O. Sporothrix schenckii Sensu Lato identification in fragments of skin lesion cultured in NNN medium for differential diagnosis of cutaneous leishmaniasis. Diagn. Microbiol. Infect. Dis. 2017;87:118–120. doi: 10.1016/j.diagmicrobio.2016.11.009. [DOI] [PubMed] [Google Scholar]
- 106.Rodrigues A.M., de Hoog S., de Camargo Z.P. Emergence of pathogenicity in the Sporothrix schenckii complex. Med Mycol. 2013;51:405–412. doi: 10.3109/13693786.2012.719648. [DOI] [PubMed] [Google Scholar]
- 107.Alvarado Z., Pereira C. Fungal diseases in children and adolescents in a referral centre in Bogota, Colombia. Mycoses. 2018;61:543–548. doi: 10.1111/myc.12774. [DOI] [PubMed] [Google Scholar]
- 108.Macías P., Ordóñez J., Arenas C.M., Rodríguez G. An eighteen-year-old man with tropical verrucous syndrome: Leishmaniasis vs, sporotrichosis. Biomedica. 2021;41:240–246. doi: 10.7705/biomedica.5757. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109.Arenas-Soto C.M., Téllez-Kling A.M., Alvarado-Álvarez Z.L. A Lesion on the Ear Resulting From Infection Acquired in the Tropics. Actas Dermosifiliogr. 2016;107:599–600. doi: 10.1016/j.ad.2015.06.016. [DOI] [PubMed] [Google Scholar]
- 110.Niklitschek S., Porras N., González S., Romero W. Sporotrichosis. Med. Clin. 2015;145:418. doi: 10.1016/j.medcli.2015.01.027. [DOI] [PubMed] [Google Scholar]
- 111.Cruz R., Vieille P., Oschilewski D. Sporothrix globosa isolation related to a case of lymphocutaneous sporotrichosis. Rev. Chil. Infectol. 2012;4:401–405. doi: 10.4067/S0716-10182012000400006. [DOI] [PubMed] [Google Scholar]
- 112.Cruz-Choappa R.M., Vieille-Oyarzo P.I., Carvajal-Silva L.C. Aislamiento de Sporothrix pallida complex en muestras clínicas y ambientales de Chile. Rev. Argent Microbiol. 2014;46:311–314. doi: 10.1016/S0325-7541(14)70088-4. [DOI] [PubMed] [Google Scholar]
- 113.García Duarte J.M., Wattiez Acosta V.R., Fornerón Viera P.M.L., Aldama Caballero A., Gorostiaga Matiauda1 G.A., Rivelli de Oddone V.B., Pereira Brunelli J.G. Sporotrichosis transmitted by domestic cat. A family case report. Rev. Del. Nacional. 2017;9:67–76. doi: 10.18004/rdn2017.0009.02.067-076. [DOI] [Google Scholar]
- 114.Aguilar Fernández G., Araújo López V. Mycosis and nocardiosis implantation: Sporotrichosis, Chromoblastomycosis, Mycetomas and Nocardiosis. Casuistics in the Central Laboratory of Public Health, Paraguay, period 1997–2019. Rev. Nac. 2020;12:1–13. doi: 10.18004/rdn2020.0012.01.001-013. [DOI] [Google Scholar]
- 115.Ramirez-Soto M., Lizarraga-Trujillo J. Granulomatous sporotrichosis: Report of two unusual cases. Rev. Chil. Infectol. 2013;5:548–553. doi: 10.4067/S0716-10182013000500013. [DOI] [PubMed] [Google Scholar]
- 116.Ramírez-Soto M.C. Sporotrichosis in the Ocular Adnexa: 21 Cases in an Endemic Area in Peru and Review of the Literature. Am. J. Ophthalmol. 2016;162:173–179.e3. doi: 10.1016/j.ajo.2015.11.015. [DOI] [PubMed] [Google Scholar]
- 117.Ramírez-Soto M.C., Malaga G. Subcutaneous mycoses in Peru: A systematic review and meta-analysis for the burden of disease. Int. J. Dermatol. 2017;56:1037–1045. doi: 10.1111/ijd.13665. [DOI] [PubMed] [Google Scholar]
- 118.Ramírez-Soto M.C., Andagua-Castro J., Lizárraga-Trujillo J. Palpebral sporotrichosis in a 6-year-old child. Int. J. Dermatol. 2016;55:e625–e626. doi: 10.1111/ijd.13383. [DOI] [PubMed] [Google Scholar]
- 119.Wolff D., Feldt T., Reifenberger J., Sebald H., Bogdana C. The brief case: Cutaneous sporotrichosis in an immunocompetent patient after travel to Peru. J. Clin. Microbiol. 2018;56:e01958-17. doi: 10.1128/JCM.01958-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 120.Rueda M., Torres N., Bravo F. Disseminated cutaneous sporotrichosis: An unusual case. Derm. Online J. 2018;24 doi: 10.5070/D32411042003. [DOI] [PubMed] [Google Scholar]
- 121.Oyarce J.A., García C., Alave J., Bustamante B. Epidemiological clinical and laboratory characterization of sporotrichosis in patients of a tertiary care hospital in Lima, Peru, from 1991 to 2014. Rev. Chil. Infectol. 2016;3:315–321. doi: 10.4067/S0716-10182016000300012. [DOI] [PubMed] [Google Scholar]
- 122.Schwalb A., Carcamo P.M., Seas C. Lymphocutaneous Sporotrichosis. Am. J. Trop. Med. Hyg. 2022;106:758–759. doi: 10.4269/ajtmh.21-1212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 123.Solorzano S., Ramirez R., Cabada M.M., Montoya M., Cazorla E. Disseminated cutaneous sporotrichosis with joint involvement in a woman with type 2 diabetes. Rev. Peru Med. Exp. Salud Publica. 2015;32:187–190. doi: 10.17843/rpmesp.2015.321.1593. [DOI] [PubMed] [Google Scholar]
- 124.Cabeza E., Arrillaga A., Dalcín L., Carbia M., Arteta Z., Perera P. Clinical and Epidemiological Characteristics of Sporotrichosis in Reference Center of Uruguay. J. Fungi. 2022;8:322. doi: 10.3390/jof8030322. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 125.Barreto L., Velásquez G., Mendoza M., Camacho E., Goncalves E., Rodríguez S., Niño-Vega G.A. Geographical distribution and ecological niche modeling of the etiological agents of human sporotrichosis in Venezuela. Braz. J. Microbiol. 2021;52:63–71. doi: 10.1007/s42770-020-00306-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 126.Mata-Essayag S., Delgado A., Colella M.T., Landaeta-Nezer M.E., Rosello A., de Salazar C.P., Olaizola C., Hartung C., Magaldi S., Velasquez E. Epidemiology of sporotrichosis in Venezuela. Int. J. Dermatol. 2013;52:974–980. doi: 10.1111/j.1365-4632.2012.05849.x. [DOI] [PubMed] [Google Scholar]
- 127.Martínez-Méndez D., Hernández-Valles R., Alvarado P., Mendoza M. Mycoses In Venezuela: Working Groups in Mycology Reported Cases (1984–2010) Rev. Iberoam. Micol. 2013;30:39–46. doi: 10.1016/j.riam.2012.10.001. [DOI] [PubMed] [Google Scholar]
- 128.Camacho E., León-Navarro I., Rodríguez-Brito S., Mendoza M., Niño-Vega G.A. Molecular epidemiology of human sporotrichosis in Venezuela reveals high frequency of Sporothrix globose. BMC Infect Dis. 2015;15:94. doi: 10.1186/s12879-015-0839-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 129.Orofino-Costa R., Marques-de-Macedo P., Messias-Rodrigues A., Bernardes-Engemann A.R. Sporotrichosis: An update on epidemiology, etiopathogenesis, laboratory and clinical therapeutics. Bras. Dermatol. 2017;92:606–620. doi: 10.1590/abd1806-4841.2017279. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 130.Rimma Z., Hernández Hernández F. Sporotrichosis: The most frequent subcutaneous mycosis in Mexico. Rev. Fac. Med. 2019;62:48–55. [Google Scholar]
- 131.Chakrabarti A., Bonifaz A., Gutierrez-Galhardo M.C., Mochizuki T., Li S. Global epidemiology of sporotrichosis. Med. Mycol. 2015;53:3–14. doi: 10.1093/mmy/myu062. [DOI] [PubMed] [Google Scholar]
- 132.de Beer Z.W., Duong T.A., Wingfield M.J. The divorce of Sporothrix and Ophiostoma: Solution to a problematic relationship. Stud. Mycol. 2016;83:165–191. doi: 10.1016/j.simyco.2016.07.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 133.Toriello C., Brunner-Mendoza C., Ruiz-Baca E., Duarte-Escalante E., Pérez-Mejía A., Reyes-Montes M.R. Sporotrichosis in Mexico. Braz. J. Microbiol. 2021;52:49–62. doi: 10.1007/s42770-020-00387-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Not applicable.